Skip to content

Opening book details…

About this Medicine article

Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies by Christophe Le Tourneau; Sandrine Faivre; Valérie Laurence; Catherine Delbaldo; Karina Vera; Veronique Girre; Judy Chiao; Sian Armour; Sheelagh Frame; Simon R. Green; Athos Gianella-Borradori; Veronique Diéras; Eric Raymond is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Christophe Le Tourneau; Sandrine Faivre; Valérie Laurence; Catherine Delbaldo; Karina Vera; Veronique Girre; Judy Chiao; Sian Armour; Sheelagh Frame; Simon R. Green; Athos Gianella-Borradori; Veronique Diéras; Eric Raymond
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
Published
2010
Language
EN
Field
Medicine (Health Sciences)

More by Christophe Le Tourneau; Sandrine Faivre; Valérie Laurence; Catherine Delbaldo; Karina Vera; Veronique Girre; Judy Chiao; Sian Armour; Sheelagh Frame; Simon R. Green; Athos Gianella-Borradori; Veronique Diéras; Eric Raymond

Browse all works by Christophe Le Tourneau; Sandrine Faivre; Valérie Laurence; Catherine Delbaldo; Karina Vera; Veronique Girre; Judy Chiao; Sian Armour; Sheelagh Frame; Simon R. Green; Athos Gianella-Borradori; Veronique Diéras; Eric Raymond